leadf
logo-loader
viewArcadia Biosciences Inc
(
NASDAQ:RKDA
)

Arcadia Biosciences raises $6.8M to fund hemp opportunities, cushion from coronavirus

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matt Plavan tells Proactive that the agricultural technology company has raised about $6.8 million by selling warrants. Plavan says the company expects to use the proceeds to pursue a range of near-term inorganic growth opportunities within its hemp business unit as well as a cushion from coronavirus. Plavan also discussed its most recent quarterly earnings.

Quick facts: Arcadia Biosciences Inc

Follow
NASDAQ:RKDA

Price: 2.04 USD

Market Cap: $45.23 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Arcadia Biosciences describes expected synergies with its recent CBD-focused...

Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17DN) CEO Matt Plavan describes to Proactive why the group recently acquired CBD-focused Lief Holdings, LLC and Live Zola, LLC. Plavan says in addition to bringing in a 'significant amount of recurring revenue' he sees synergies within the two groups,...

on 05/19/2021

2 min read